MEDNAX ($MD) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of $0.33 per share, beating estimates of $0.25 by $0.08. The company also reported revenue of $458,360,000, missing estimates of $465,042,940 by $-6,682,940.
You can see Quiver Quantitative's $MD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDNAX Insider Trading Activity
MEDNAX insiders have traded $MD stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MD stock by insiders over the last 6 months:
- MARK S ORDAN sold 27,600 shares for an estimated $423,660
- MARY ANN E MOORE (EVP, GC, Chief Admin Off & Sec) sold 8,108 shares for an estimated $129,728
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDNAX Hedge Fund Activity
We have seen 109 institutional investors add shares of MEDNAX stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP removed 5,126,560 shares (-62.0%) from their portfolio in Q4 2024, for an estimated $67,260,467
- FMR LLC added 2,896,518 shares (+29433.2%) to their portfolio in Q4 2024, for an estimated $38,002,316
- PACER ADVISORS, INC. added 2,705,151 shares (+inf%) to their portfolio in Q4 2024, for an estimated $35,491,581
- MORGAN STANLEY removed 2,159,435 shares (-62.2%) from their portfolio in Q4 2024, for an estimated $28,331,787
- AMERICAN CENTURY COMPANIES INC added 1,500,485 shares (+628.2%) to their portfolio in Q4 2024, for an estimated $19,686,363
- WEISS ASSET MANAGEMENT LP removed 912,818 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,976,172
- INVENOMIC CAPITAL MANAGEMENT LP removed 780,983 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $10,246,496
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
